Literature DB >> 14699634

Cardiovascular potential of embryonic stem cells.

Sharon Gerecht-Nir1, Bettina Fishman, Joseph Itskovitz-Eldor.   

Abstract

Initial events involved in the process of heart formation consist of myocardial differentiation as well as development of endothelial and endocardial tissues. As only limited means are allocated to the studying of cardiovascular system development, embryonic stem cells (ESCs) isolated from the inner cell mass (ICM) of developing mice or human blastocysts offer the first step toward the understanding of these complex and intriguing events. ESCs are able to differentiate into a wide range of cell types, including various vascular cells and cardiomyocytes, and their self-renewal capability renders them a unique, homogeneous, and unlimited preliminary population of cells for the investigation of early developmental events of cardiovascular system and lineage commitment. This review summarizes the accumulated knowledge of the cellular and molecular mechanisms involved in the development of the cardiovascular system. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14699634     DOI: 10.1002/ar.a.10136

Source DB:  PubMed          Journal:  Anat Rec A Discov Mol Cell Evol Biol        ISSN: 1552-4884


  3 in total

Review 1.  Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation.

Authors:  Paolo Angelini; Roger R Markwald
Journal:  Tex Heart Inst J       Date:  2005

2.  Morphological characterization of GFP stably transfected adult mesenchymal bone marrow stem cells.

Authors:  Stefania Raimondo; Claudia Penna; Pasquale Pagliaro; Stefano Geuna
Journal:  J Anat       Date:  2006-01       Impact factor: 2.610

3.  Programming and isolation of highly pure physiologically and pharmacologically functional sinus-nodal bodies from pluripotent stem cells.

Authors:  Julia Jeannine Jung; Britta Husse; Christian Rimmbach; Stefan Krebs; Juliane Stieber; Gustav Steinhoff; Andreas Dendorfer; Wolfgang-Michael Franz; Robert David
Journal:  Stem Cell Reports       Date:  2014-04-17       Impact factor: 7.765

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.